Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Xuemeng Xu, Peng Qiu, Xianjie Jiang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1357-1370
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer
Bo Xie, Juntao Lin, Xianwu Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 76
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 51
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications
Yuqiang Liu, Yu Zhao, Huisheng Song, et al.
Cancer Letters (2024) Vol. 597, pp. 217076-217076
Open Access | Times Cited: 16
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 15
CDCA8, a mitosis-related gene, as a prospective pan-cancer biomarker: implications for survival prognosis and oncogenic immunology
Hanjie Hu
American Journal of Translational Research (2024) Vol. 16, Iss. 2, pp. 432-445
Open Access | Times Cited: 15
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Signaling, cancer cell plasticity, and intratumor heterogeneity
Marco Cordani, Ilaria Dando, Giulia Ambrosini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis
Jiancheng He, Jianfeng Yi, Li Ji, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 9
From Data to Cure: A Comprehensive Exploration of Multi-omics Data Analysis for Targeted Therapies
Arnab Mukherjee, Suzanna Abraham, Akshita Singh, et al.
Molecular Biotechnology (2024)
Open Access | Times Cited: 8
Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma
Jiazhou Ye, Xing Gao, Xi huang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 8
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance
C. Raman Suri, Babita Pande, Lakkakula Suhasini Sahithi, et al.
Cancer Drug Resistance (2025)
Open Access | Times Cited: 1
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression
Peng Qiu, Lujuan Wang, Ying Long, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Altered glycosylation in cancer: molecular functions and therapeutic potential
Xuemeng Xu, Qiu Peng, Xianjie Jiang, et al.
Cancer Communications (2024) Vol. 44, Iss. 11, pp. 1316-1336
Open Access | Times Cited: 7
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway
Phonpilas Thongpon, Kitti Intuyod, Sasitorn Chomwong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
The relationship and clinical significance of lactylation modification in digestive system tumors
Gang Wang, Xiaosu Zou, Qicong Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Tumor energy metabolism: implications for therapeutic targets
Youwu Hu, Wanqing Liu, WanDi Fang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Targeting the myeloid microenvironment in neuroblastoma
Marjolein C. Stip, Loes Teeuwen, Miranda P. Dierselhuis, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Exploiting the Achilles’ heel of cancer: disrupting glutamine metabolism for effective cancer treatment
Yuxin Fan, Xue Han, Zhimin Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 5
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics
Nazanin Zohourian, James A. L. Brown
Epigenomics (2024) Vol. 16, Iss. 9, pp. 671-680
Closed Access | Times Cited: 5
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders
Sumel Ashique, Neeraj Mishra, Shubhrajit Mantry, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
Triterpenoid ursolic acid regulates the environmental carcinogen benzo[a]pyrene-driven epigenetic and metabolic alterations in SKH-1 hairless mice for skin cancer interception
Md Shahid Sarwar, Christina N. Ramirez, Hsiao‐Chen Dina Kuo, et al.
Carcinogenesis (2024) Vol. 45, Iss. 5, pp. 288-299
Closed Access | Times Cited: 4
Unveiling the Therapeutic Potential of Folate-Dependent One-Carbon Metabolism in Cancer and Neurodegeneration
Ana Filipa Sobral, Andrea Cunha, Vera Silva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9339-9339
Open Access | Times Cited: 4
APOM Modulates the Glycolysis Process in Liver Cancer Cells by Controlling the Expression and Activity of HK2 via the Notch Pathway
Shuangqiu Du, Jingtong Wang, Miaomiao Liu, et al.
Biochemical Genetics (2025)
Closed Access
Page 1 - Next Page

Scroll to top